Insights from 2023 ASH Annual Meeting
D

Chronic GVHD: Results from Agave-201 - Axatilimab at 3 Different Doses

By Insights from 2023 ASH Annual Meeting FEATURING Daniel Wolff
By Insights from 2023 ASH Annual Meeting FEATURING Daniel Wolff
55 views
December 29, 2023
0 Comments
Login to view comments. Click here to Login

Featured Video

01:29
Incyte

Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Related Content

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
22:37
Insights from 2023 ASH Annual Meeting

AML and MDS Highlights & Key Takeaways

Feat. T. Badar
16:57
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Lymphoma Highlights"

Feat. B. D. Cheson
13:07
Moffitt Cancer Center

R/R DLBCL: Are Bispecific Antibodies Superior to CAR-T?

Feat. J. Chavez
17:51
Indy Hematology Review

Treatment of AML: Managing the Patient When Transplant Is Not an Opt…

Feat. H. Erba
31:53
Indy Hematology Review

HSCT in 2024: What Every Hematologist Needs to Know

Feat. R. Childs
04:16
Luke Fletcher

Efficacy and Safety of Asciminib in Ph+ CML

22:09
Scripps Health

New Updates in Frontline DLBCL

Feat. L. Nastoupil
09:51
i3 Health

MRD Testing in Leukemias: When Negativity Is a Positive Thing

Feat. N. S. Raje
09:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary OS Analysis of the Phase 3 Random…

Feat. J. Westin
27:47
Indy Hematology Review

Current Advances in the Treatment of Aggressive B- and T-Cell Lympho…

Feat. S. Smith
10:04
Tara Graff

How to Incorporate Bispecific Antibodies Into Your NHL Practice: A P…

12:49
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Treatment of Relapsed HL - Updated Options…

Feat. P. Johnson
11:12
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "SWOG S1826, a Randomized Study of Nivo-AV…

Feat. A. Herrera
08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou
35:27
Louisville Hematology Highlights

Updates on Management of DLBCL

Feat. J. Leonard
16:55
Moffitt Cancer Center

Making Sense of the New Classification Systems for MDS in 2024

Feat. R. Komrokji
19:10
5th SOHO Italy Annual Conference

SOHO Italy 2023: How I Treat AML at MD Anderson Cancer Center

Feat. H. Kantarjian
08:23
Total Health

R/R DLBCL Case Discussion: 81 y/o Male Needing 3rd Line Treatment

Feat. J. Chandler, B. Randolph, M. Onciu
21:56
Indy Hematology Review

Emerging and Current Treatment for Hodgkin Lymphoma in 2024

Feat. S. Ansell